DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Herman SE, Mustafa RZ, Gyamfi JA, Pittaluga S, Chang S, Chang B. et al.
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.
Blood 2014;
123: 3286-95
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.